| ［1］ Williams L T.Signal transduction by the platelet-derived growth Factor receptor.Science,1989,243:1564~1570 ［2］ Heldin C,stman A,Eriksson U.New members of the platelet-derived Growth factor family of mitogens.Arch Biochem Biophys, 2002,398:284~290 ［3］ Wang L H, Yang J Y,Wu C F.Reseach advances on signal transduction Pathways as therapy targets in gastric cancer.Chin Phamacol Bull,2007,23(2):147~150 ［4］ Leppnen O,Miyazawa K,Pietras K,et al.Predimerization of Recombinant Platelet-Derived Growth Factor Receptor Extracellular Domains Increases Antagonistic Potency.Biochemistry,2000,39:2370~2375 ［5］ Levitzki A.PDGF receptor kinase inhibitors for the treatment of PDGF driven diseases.Cytokine&Growth Factor Reviews,2004,15(4):229~235 ［6］ 张秀华，林莉萍，丁健.靶向血小板源生长因子受体酪氨酸激酶抑制剂的临床研究进展.中国新药与临床杂志，2006,25(6):454~458 Zhang X H,Lin L P,Ding J.Chin J New Drugs Clin Rem,2006,25(6):454~458 ［7］ Novick D,Rubinstein M.The tale of solube receptors and binding proteins:From bench to bedside.Cytokine&Growth Factor Reviews,2007,18(1-2):525~533 ［8］ Mitsuyama K,Sata M,John-SR.Interleukin-6 trans-signaling in inflammatory bowel disease.Cytokine&Growth Factor Reviews,2006,17(6):451~461 ［9］ Rubin L A, Kurman C C, Fritz M E,et al.Solube interleukin 2 receptors are released from actived human lymphoid cells in vitro.Immunol, 1985,135:3172~3177 ［10］ Bickel M,Dobbelaere D,Machado J,et al.Solube interleukin-1 receptor—reverse signaling in innate immunoregulation. Cytokine&Growth Factor Reviews,2001,12(1):27~32 ［11］ 张国强，刘志刚，俞炜源.哺乳动物细胞高效表达系统研究进展.生物技术通讯，2005，16(1):56~59 Zhang G Q,Liu Z G,Yu W Y.Letters in Biotechnology,2005,16(1):56~59 |
